None of the participants had pre-pregnancy HTN, and only a few metformin- or insulin-treated patients developed HTN and pre-eclampsia during pregnancy (3% and 2.1%, respectively), while no patients in the diet group developed these conditions. This evidence concerns the gene INS and hypertensive disorder.